StonvexLoading…
StonvexStonvexStonvexCore line items from CLOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $749.19M | $1.92B | $1.44B | $939.95M |
Operating Income | $27.33M | $-85.53M | $-36.21M | $-11.83M |
Net Income | $27.33M | $-85.55M | $-24.38M | $-10.58M |
EPS (Diluted) | $0.05 | $-0.17 | $-0.07 | $-0.02 |
Total Assets | $697.73M | $541.01M | $559.66M | $574.99M |
Total Liabilities | $358.30M | $232.31M | $218.73M | $230.81M |
Cash & Equivalents | $173.26M | $78.30M | $190.06M | $188.65M |
Free Cash Flow OCF − CapEx | $107.04M | $-68.98M | $-228.00K | $-11.64M |
Shares Outstanding | 532.50M | 511.97M | 510.19M | 508.89M |